MetaVia Inc. (MTVA) stock
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06−0.19 (-15.20%)
Close on Nov 18, 2026Market cap $6.98MP/E –Yield –
MetaVia shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
MetaVia's shares outstanding was 6M at Jun 30, 2026. For fiscal 2025 it was 2M, up 150.4% from the year before. Over ten years it grew 131.7% a year on average. The highest annual figure on record is 2M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +150.4% |
| FY2024 | Dec 31, 2024 | 1M | +53.0% |
| FY2023 | Dec 31, 2023 | 0M | +1476.3% |
| FY2022 | Dec 31, 2022 | 0M | +233.6% |
| FY2021 | Dec 31, 2021 | 0M | +42.7% |
| FY2020 | Dec 31, 2020 | 0M | +210.4% |
| FY2019 | Dec 31, 2019 | 0M | +22.9% |
| FY2018 | Dec 31, 2018 | 0M | +12.9% |
| FY2017 | Dec 31, 2017 | 0M | +78.3% |
| FY2016 | Dec 31, 2016 | 0M | +102.0% |
| FY2015 | Dec 31, 2015 | 0M | +88.6% |
| FY2014 | Dec 31, 2014 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 6M | +326.8% |
| Q1 FY2026 | Mar 31, 2026 | 5M | +420.8% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +145.1% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +139.0% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +181.6% |
| Q1 FY2025 | Mar 31, 2025 | 1M | +101.7% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +101.6% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +101.2% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +7.3% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +0.6% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +4482.2% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +4469.1% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +4454.0% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +4488.5% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +19.6% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +21.2% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +23.3% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +60.7% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +35.7% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +34.9% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +37.9% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +204.9% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +217.9% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +215.6% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +203.3% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +3.9% |
| Q3 FY2019 | Sep 30, 2019 | 0M | -0.4% |
| Q2 FY2019 | Jun 30, 2019 | 0M | -0.2% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +14.2% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +34.1% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +34.2% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +34.2% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +30.7% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +16.9% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +52.1% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?